EMDB/PDB/SASBDBから引用されている文献のデータベース

キーワード
構造解析手法	All X線回折 NMR 電子顕微鏡小角散乱中性子線回折線維回折粉末回折赤外分光 EPR FRET 理論モデルハイブリッド
著者・登録者
ジャーナル
IF	>30 >20 >10 >5 all

タイトル	Merging the binding sites of aldose and aldehyde reductase for detection of inhibitor selectivity-determining features.
ジャーナル・号・ページ	J. Mol. Biol., Vol. 379, Page 991-1016, Year 2008
掲載日	2007年3月31日 (構造データの登録日)
著者	Steuber, H. / Heine, A. / Podjarny, A. / Klebe, G.
リンク	J. Mol. Biol. / PubMed:18495158
手法	X線回折
解像度	1.42 - 1.75 Å
構造データ	PDB-2pd5: Human aldose reductase mutant V47I complexed with zopolrestat 手法: X-RAY DIFFRACTION / 解像度: 1.6 Å PDB-2pd9: Human aldose reductase mutant V47I complexed with fidarestat. 手法: X-RAY DIFFRACTION / 解像度: 1.55 Å PDB-2pdb: Human aldose reductase mutant F121P complexed with zopolrestat. 手法: X-RAY DIFFRACTION / 解像度: 1.6 Å PDB-2pdc: Human aldose reductase mutant F121P complexed with IDD393. 手法: X-RAY DIFFRACTION / 解像度: 1.65 Å PDB-2pdf: Human aldose reductase mutant L300P complexed with zopolrestat. 手法: X-RAY DIFFRACTION / 解像度: 1.56 Å PDB-2pdg: Human aldose reductase with uracil-type inhibitor at 1.42A. 手法: X-RAY DIFFRACTION / 解像度: 1.42 Å PDB-2pdh: Human aldose reductase mutant L300P complexed with uracil-type inhibitor at 1.45 A. 手法: X-RAY DIFFRACTION / 解像度: 1.45 Å PDB-2pdi: Human aldose reductase mutant L300A complexed with zopolrestat at 1.55 A. 手法: X-RAY DIFFRACTION / 解像度: 1.55 Å PDB-2pdj: Human aldose reductase mutant L300A complexed with IDD393. 手法: X-RAY DIFFRACTION / 解像度: 1.57 Å PDB-2pdk: Human aldose reductase mutant L301M complexed with sorbinil. 手法: X-RAY DIFFRACTION / 解像度: 1.55 Å PDB-2pdl: Human aldose reductase mutant L301M complexed with tolrestat. 手法: X-RAY DIFFRACTION / 解像度: 1.47 Å PDB-2pdm: Human aldose reductase mutant S302R complexed with zopolrestat. 手法: X-RAY DIFFRACTION / 解像度: 1.75 Å PDB-2pdn: Human aldose reductase mutant S302R complexed with uracil-type inhibitor. 手法: X-RAY DIFFRACTION / 解像度: 1.7 Å PDB-2pdp: Human aldose reductase mutant S302R complexed with IDD 393. 手法: X-RAY DIFFRACTION / 解像度: 1.65 Å PDB-2pdq: Human aldose reductase mutant C303D complexed with uracil-type inhibitor. 手法: X-RAY DIFFRACTION / 解像度: 1.73 Å PDB-2pdu: Human aldose reductase mutant C303D complexed with IDD393. 手法: X-RAY DIFFRACTION / 解像度: 1.55 Å PDB-2pdw: Human aldose reductase mutant C303D complexed with fidarestat. 手法: X-RAY DIFFRACTION / 解像度: 1.55 Å PDB-2pdx: Human aldose reductase double mutant S302R-C303D complexed with zopolrestat. 手法: X-RAY DIFFRACTION / 解像度: 1.65 Å PDB-2pdy: Human aldose reductase double mutant S302R-C303D complexed with fidarestat. 手法: X-RAY DIFFRACTION / 解像度: 1.65 Å
化合物	ChemComp-NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE ChemComp-ZST: 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL-2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID / ゾポルレスタット ChemComp-HOH: WATER ChemComp-FID: (2S,4S)-2-AMINOFORMYL-6-FLUORO-SPIRO[CHROMAN-4,4'-IMIDAZOLIDINE]-2',5'-DIONE / フィダレスタット / 阻害剤YM ChemComp-393: (5-CHLORO-2-{[(3-NITROBENZYL)AMINO]CARBONYL}PHENOXY)ACETIC ACID ChemComp-47D: {3-[(5-CHLORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL}ACETIC ACID / 3-[(5-クロロベンゾチアゾ-ル-2-イル)メチル]-2,4-ジオキソ-1,2,3,4-テトラヒドロピリミジン-1-(以下略) ChemComp-SBI: SORBINIL / ソルビニル / 阻害剤YM ChemComp-TOL: TOLRESTAT / トルレスタット / 阻害剤*YM
由来	homo sapiens (ヒト)
キーワード	OXIDOREDUCTASE / TIM barrel / V47I mutant / protein-ligand complex / TIM-barrel / mutant